39 drug samples including Glenmark Telma H fail to clear CDSCO test, 1 declared misbranded Susmita Roy17 March 2022 3:21 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), has flagged 39...
Natco Pharma gets CDSCO nod to manufacture, market anti neoplastic drug Idelalisib Dr. Divya Colin16 March 2022 6:52 PM ISTNew Delhi: In a significant development, Natco Pharma has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control...
NPPA Panel fixes retail price of antibiotic FDC marketed by Abbott, details Dr. Divya Colin15 March 2022 6:17 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of modified released tablet containing cefixime,...
Bristol Myers Squibb Nivolumab marketing approval to be revoked for hepatocellular carcinoma: CDSCO panel Dr. Divya Colin14 March 2022 6:30 PM ISTNew Delhi: In a major setback for Bristol Myers Squibb, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
Unethical Marketing Practices Of Pharma Companies: SC to examine UCPMP code implementation Medical Dialogues Bureau12 March 2022 12:34 PM IST"No enforceable law exists which regulates the promotion of drugs by pharmaceutical companies vis-Ã -vis healthcare professionals, and therefore...
Setback: GSK proposal to market Meningococcal group B Vaccine rejected by CDSCO panel Dr. Divya Colin11 March 2022 5:08 PM ISTNew Delhi: In the major setback to GSK, citing that the firm has not submitted any safety and immunogenicity data in Indian population, the Subject...
Roche India Atezolizumab marketing approval to be revoked for two indications: CDSCO panel Susmita Roy10 March 2022 6:50 PM ISTNew Delhi: In a major setback to Roche Products (India), the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
Sanofi gets CDCSO panel okay to study Antiasthmatic drug Dupilumab Dr. Divya Colin9 March 2022 6:58 PM ISTNew Delhi: Pharmaceutical major, Sanofi has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization...
GSK gets CDSCO panel nod to market Mepolizumab for two rare disease indications Dr. Divya Colin8 March 2022 4:11 PM ISTNew Delhi: Pharmaceutical major, GSK has got a go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization...
NPPA panel fixes retail price of Zuventus antihypertensive FDC Efonidipine, telmisartan, details Dr. Divya Colin7 March 2022 6:45 PM IST New Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of uncoated bilayered tablet containing...
NPPA panel fixes retail price of Intas Pharma Normal Human Immunoglobulin 5% solution Dr. Divya Colin6 March 2022 12:30 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority(NPPA) panel has fixed the retail price of each vial of Normal Human Immunoglobulin 5%...
Lupin gets CDSCO panel okay to manufacture, market tuberculosis drug Rifapentine Dr. Divya Colin5 March 2022 5:35 PM ISTNew Delhi: Drug major, Lupin has got a go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization to (CDSCO)...
